Inclisiran (KJX839)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inclisiran (KJX839), covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia [Phase 4]